Kevin Lorenz is Director of Fortress Biotech, Inc.. Currently has a direct ownership of 24,304 shares of FBIO, which is worth approximately $43,747. The most recent transaction as insider was on Jan 01, 2024, when has been sold 3,333 shares (Common Stock, par value $0.001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.3K
0% 3M change
92.27% 12M change
Total Value Held $43,747

Kevin Lorenz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 01 2024
BUY
Grant, award, or other acquisition
-
3,333 Added 12.06%
24,304 Common Stock, par valu...
Jan 01 2023
BUY
Grant, award, or other acquisition
-
50,000 Added 13.71%
314,572 Common Stock, par valu...
Jan 01 2022
BUY
Grant, award, or other acquisition
-
50,000 Added 15.89%
264,572 Common Stock, par valu...
Jan 01 2021
BUY
Open market or private purchase
-
50,000 Added 18.9%
214,582 Common Stock, par valu...
KL

Kevin Lorenz

Director
New York, NY

Track Institutional and Insider Activities on FBIO

Follow Fortress Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FBIO shares.

Notify only if

Insider Trading

Get notified when an Fortress Biotech, Inc. insider buys or sells FBIO shares.

Notify only if

News

Receive news related to Fortress Biotech, Inc.

Track Activities on FBIO